- Home
- VANI vs RLAY Comparison
VANI vs RLAY Comparison
Compare VANI & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VANI
- RLAY
- Stock Information
- Founded
- VANI 1998
- RLAY 2015
- Country
- VANI United States
- RLAY United States
- Employees
- VANI N/A
- RLAY N/A
- Industry
- VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- VANI Health Care
- RLAY Health Care
- Exchange
- VANI Nasdaq
- RLAY Nasdaq
- Market Cap
- VANI 68.1M
- RLAY 576.1M
- IPO Year
- VANI 2014
- RLAY 2020
- Fundamental
- Price
- VANI $1.26
- RLAY $3.63
- Analyst Decision
- VANI Strong Buy
- RLAY Strong Buy
- Analyst Count
- VANI 1
- RLAY 11
- Target Price
- VANI $4.00
- RLAY $18.40
- AVG Volume (30 Days)
- VANI 146.6K
- RLAY 1.6M
- Earning Date
- VANI 08-12-2025
- RLAY 08-05-2025
- Dividend Yield
- VANI N/A
- RLAY N/A
- EPS Growth
- VANI N/A
- RLAY N/A
- EPS
- VANI N/A
- RLAY N/A
- Revenue
- VANI N/A
- RLAY $7,679,000.00
- Revenue This Year
- VANI N/A
- RLAY $14.31
- Revenue Next Year
- VANI N/A
- RLAY N/A
- P/E Ratio
- VANI N/A
- RLAY N/A
- Revenue Growth
- VANI N/A
- RLAY N/A
- 52 Week Low
- VANI $0.91
- RLAY $1.78
- 52 Week High
- VANI $1.50
- RLAY $10.72
- Technical
- Relative Strength Index (RSI)
- VANI 58.97
- RLAY 63.22
- Support Level
- VANI $1.24
- RLAY $3.10
- Resistance Level
- VANI $1.33
- RLAY $3.75
- Average True Range (ATR)
- VANI 0.06
- RLAY 0.23
- MACD
- VANI 0.00
- RLAY 0.03
- Stochastic Oscillator
- VANI 59.09
- RLAY 84.42
About VANI Vivani Medical Inc. (DE)
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).